ArticleFrontiers in immunology2025

Golidocitinib was used for the first time to treat refractory NK-Large Granular lymphocytic leukemia with a STAT3 mutation, accompanied by hemolytic anemia: a case report.

Hongyuan Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.